Evidence map›Paper›PMID 39126467›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

Efficient Enrichment of Synchronized Mouse Spermatocytes Suitable for Genome-Wide Analysis.

Agustin Carbajal, Irma Gryniuk, Rodrigo O de Castro, Roberto J Pezza

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Agustin CarbajalCell Cycle and Cancer Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Irma GryniukCell Cycle and Cancer Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Rodrigo O de CastroCell Cycle and Cancer Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Roberto J PezzaCell Cycle and Cancer Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA. pezzar@omrf.org.

Funding

Epigenetic control of meiotic recombination in mammals - Equipment SupplementR01GM125803 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI PEZZA, ROBERTO JOSE · 2018 to 2021
$1.8M
Development of a lacO/lacI based flourescence reporter-operator system to study chromosome dynamics in miceR21HD103562 · NICHD · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI PEZZA, ROBERTO JOSE · 2021 to 2022
$495k
NICHD NIH HHS R21 HD103562NIGMS NIH HHS R01 GM125803
6 · The paper itself

Abstract

Chromatin undergoes extensive remodeling during meiosis, leading to specific patterns of gene expression and chromosome organization, which ultimately controls fundamental meiotic processes such as recombination and homologous chromosome associations. Recent game-changing advances have been made by analysis of chromatin binding sites of meiotic specific proteins genome-wide in mouse spermatocytes. However, further progress is still highly dependent on the reliable isolation of sufficient quantities of spermatocytes at specific stages of prophase I. Here, we describe a combination of methodologies we adapted for rapid and reliable isolation of synchronized fixed mouse spermatocytes. We show that chromatin isolated from these cells can be used to study chromatin-binding sites by ChIP-seq. High-quality data we obtained from INO80 ChIP-seq in zygotene cells was used for functional analysis of chromatin-binding sites.

Indexed as

ChromatinChromatin Immunoprecipitation SequencingSpermatocytesAnimalsBinding SitesChromatin ImmunoprecipitationMaleMeiosisMiceChromatinChIP-seqGenomic analysisMouse spermatocytesSpermatocyte fraction enrichment

Identifiers

PMID39126467
PMCPMC12536511

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.